Trials / Completed
CompletedNCT01952678
Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET)
A Retrospective Clinical Study to Compare the Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images in Non-Caucasian and Caucasian Subjects With Parkinson's Disease (PD) or Essential Tremor (ET)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 204 (actual)
- Sponsor
- GE Healthcare · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to determine if the diagnostic performance of DaTscan™ single photon emission computed tomography (SPECT) imaging is different in non-Caucasian subjects compared with Caucasian subjects with movement disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | DaTscan™ - Non-Caucasian Participants | Participants who previously administered DaTscan™ and had undergone SPECT imaging of the brain per local practice at each institution. |
| OTHER | DaTscan™ - Caucasian Participants | Participants who previously administered DaTscan™ and had undergone SPECT imaging of the brain per local practice at each institution. |
Timeline
- Start date
- 2013-07-30
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2013-09-30
- Last updated
- 2018-08-02
- Results posted
- 2018-08-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01952678. Inclusion in this directory is not an endorsement.